Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Odyssey Therapeutics Reports Increased Losses and No Collaboration Revenue in Latest 10-Q Filing
Odyssey Therapeutics Reports $38.3 Million Net Loss in Q1 2026, Completes IPO Raising $278.7 Million